logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
delete
arrow
返回

university of california irvine

0H指数
95论文数
0被引数
收录论文 19
发表时间
logo
Impact of Updated Clinical Practice Guidelines on Outpatient Treatment for Clostridioides difficile Infection and Associated Clinical Outcomes更新的临床实践指南对艰难梭菌感染门诊治疗及相关临床结局的影响
errOPEN FORUM INFECTIOUS DISEASES
IF3.8
err2022-09-02
err1
errOAAI
errDubberke, Erik R.; Puckett, Justin T.; Obi, Engels N.; Kamal-Bahl, Sachin; Desai, Kaushal; Stuart, Bruce; Doshi, Jalpa A.
err分享
err收藏
Practical Next Steps in Improving Value Measurement and Use
errVALUE IN HEALTH
IF6
err2019-06-01
err1
errOAAI
errOllendorf, Daniel A.; Kamal-Bahl, Sachin; Gleason, Patrick P.; Schrandt, Suzanne; McElwee, Newell
err分享
err收藏
Specific Value Assessment Considerations
errVALUE IN HEALTH
IF6
err2019-06-01
err4
errOAAI
errKamal-Bahl, Sachin; Towse, Adrian; Spurgin, Liz; Danzon, Patricia M.
err分享
err收藏
IMPACT OF TREATMENT DELAYS ON PATIENT OUTCOMES AND IMPLICATIONS FOR MEDICARE POLICY
errVALUE IN HEALTH
IF6
err2019-05-01
err0
errOAAI
errDougherty, S.; Soh, C.; Vandigo, J.; Kamal-Bahl, S.
err分享
err收藏
Payer and Pharmaceutical Manufacturer Considerations for Outcomes-Based Agreements in the United States.
errVALUE IN HEALTH
IF6
err2018-01-01
err16
errOAAI
errBrown, Joshua D.; Sheer, Rich; Pasquale, Margaret; Sudharshan, Lavanya; Axelsen, Kirsten; Subedi, Prasun; Wiederkehr, Daniel; Brownfield, Fred; Kamal-Bahl, Sachin
err分享
err收藏
A Review of Empirical Analyses of Disinvestment Initiatives
errVALUE IN HEALTH
IF6
err2017-07-01
err28
errOAAI
errChambers, James D.; Salem, Mark N.; D'Cruz, Brittany N.; Subedi, Prasun; Kamal-Bahl, Sachin J.; Neumann, Peter J.
err分享
err收藏
Toward a Broader Concept of Value: Identifying and Defining Elements for an Expanded Cost-Effectiveness Analysis
errVALUE IN HEALTH
IF6
err2017-02-01
err89
errOAAI
errGarrison, Louis P., Jr.; Kamal-Bahl, Sachin; Towse, Adrian
err分享
err收藏
Estimating Population Health Benefits Associated with Specialty and Traditional Drugs in the Year Following Product Approval
errAPPLIED HEALTH ECONOMICS AND HEALTH POLICY
IF3.3
err2016-11-10
err3
PREAI
errChambers, James D.; Thorat, Teja; Wilkinson, Colby L.; Salem, Mark; Subedi, Prasun; Kamal-Bahl, Sachin J.; Neumann, Peter J.
err分享
err收藏
Financing a Cure for Diabetes in a Multipayer Environment
errVALUE IN HEALTH
IF6
err2016-09-01
err13
errOAAI
errBasu, Anirban; Subedi, Prasun; Kamal-Bahl, Sachin
err分享
err收藏
FINANCING A CURE FOR DIABETES IN A MULTI-PAYER ENVIRONMENT
errVALUE IN HEALTH
IF6
err2015-05-01
err0
errOAAI
errBasu, A.; Kamal-Bahl, S.; Subedi, P.
err分享
err收藏
CHALLENGES FACED BY DECISION MAKERS FROM MIDDLE INCOME COUNTRIES IN TRANSFERRING PHARMACOECONOMIC DATA AND ANALYSES FROM OTHER JURISDICTIONS
errVALUE IN HEALTH
IF6
err2014-05-01
err0
PREAI
errDrummond, M.; Augustovski, F.; Kalo, Z.; Yang, B. M.; Pichon-Riviere, A.; Bae, E. Y.; Kamal-Bahl, S.
err分享
err收藏
The lifetime medical cost burden of overweight and obesity: Implications for obesity prevention
errOBESITY
IF4.7
err2012-09-06
err153
errOAAI
errFinkelstein, Eric A.; Trogdon, Justin G.; Brown, Derek S.; Allaire, Benjamin T.; Dellea, Pam S.; Kamal-Bahl, Sachin J.
err分享
err收藏
Patients' Experiences of Niacin-Induced Flushing in Clinical Practice: A Structured Telephone Interview
errCLINICAL THERAPEUTICS
IF3.6
err2009-01-01
err22
PREAI
errKamal-Bahl, Sachin; Watson, Douglas J.; Ambegaonkar, Baishali M.
err分享
err收藏
Indirect costs of obesity: a review of the current literature
errOBESITY REVIEWS
IF7.4
err2008-08-11
err300
PREAI
errTrogdon, J. G.; Finkelstein, E. A.; Hylands, T.; Dellea, P. S.; Kamal-Bahl, S. J.
err分享
err收藏
Prevalence and extent of dyslipidemia and recommended lipid levels in US adults with and without cardiovascular comorbidities: The National Health and Nutrition Examination Survey 2003-2004
errAMERICAN HEART JOURNAL
IF3.5
err2008-07-01
err144
PREAI
errGhandehari, Heli; Kamal-Bahl, Sachin; Wong, Nathan D.
err分享
err收藏
The impact of physician attitudes and beliefs on treatment decisions - Lipid therapy in high-risk patients
errMEDICAL CARE
IF2.8
err2006-05-01
err23
PREAI
errFoley, KA; Denke, MA; Kamal-Bahl, S; Simpson, R; Berra, K; Sajjan, S; Alexander, CM
err分享
err收藏
Persistence with newly-initiated extended-release niacin versus other lipid modifying drug classes in clinical practice
errVALUE IN HEALTH
IF6
err2006-05-01
err0
errOAAI
errKamal-Bahl, S; Burke, T; Watson, D; Wentworth, C; Ma, L
err分享
err收藏
How do incentive-based formularies influence drug selection and spending for hypertension?
errHEALTH AFFAIRS
IF8.1
err2004-01-01
err45
PREAI
errKamal-Bahl, S; Briesacher, B
err分享
err收藏
Changes in functional disability levels and medical expenditures among elderly persons
errVALUE IN HEALTH
IF6
err2003-05-01
err0
errOAAI
errKamal-Bahl, S; Stuart, B; Briesacher, B; Doshi, J
err分享
err收藏

研究方向

暂时未获取到该数据
合作学者
合作期刊
N
Nathan D. Wong
H 指数: 105 · 论文数: 830
P
Peter J. Neumann
H 指数: 84 · 论文数: 513
E
Eric Finkelstein
H 指数: 71 · 论文数: 550
E
Erik R. Dubberke
H 指数: 65 · 论文数: 371
T
Terrence R. Burke
H 指数: 63 · 论文数: 470
查看更多